Small Molecule Inhibitors for Cancer Metabolism: Promising Prospects to Be Explored

Overview

Journal J Cancer Res Clin Oncol

Specialty Oncology

Date 2023 Mar 31

PMID 37002510

Authors

Dan Liu

Hongping Wang

Xingxing Li

Jifang Liu

Yanling Zhang

Jing Hu

Affiliations

Soon will be listed here.

Abstract

Background: Abnormal metabolism is the main hallmark of cancer, and cancer metabolism plays an important role in tumorigenesis, metastasis, and drug resistance. Therefore, studying the changes of tumor metabolic pathways is beneficial to find targets for the treatment of cancer diseases. The success of metabolism-targeted chemotherapy suggests that cancer metabolism research will provide potential new targets for the treatment of malignant tumors.

Purpose: The aim of this study was to systemically review recent research findings on targeted inhibitors of tumor metabolism. In addition, we summarized new insights into tumor metabolic reprogramming and discussed how to guide the exploration of new strategies for cancer-targeted therapy.

Conclusion: Cancer cells have shown various altered metabolic pathways, providing sufficient fuel for their survival. The combination of these pathways is considered to be a more useful method for screening multilateral pathways. Better understanding of the clinical research progress of small molecule inhibitors of potential targets of tumor metabolism will help to explore more effective cancer treatment strategies.

Citing Articles

Lipid metabolism associated crosstalk: the bidirectional interaction between cancer cells and immune/stromal cells within the tumor microenvironment for prognostic insight.

Lin Z, Hua G, Hu X Cancer Cell Int. 2024; 24(1):295.

PMID: 39174964 PMC: 11342506. DOI: 10.1186/s12935-024-03481-4.

Pyruvate Kinase Inhibitor Screening and Identification of Key Active Amino Acid Residues.

Li F, Zhao P, Wang S, Luo W, Xia Y, Li D Microorganisms. 2024; 12(6).

PMID: 38930523 PMC: 11205445. DOI: 10.3390/microorganisms12061141.

References

Abdel-Wahab A, Mahmoud W, Al-Harizy R . Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy. Pharmacol Res. 2019; 150:104511. DOI: 10.1016/j.phrs.2019.104511. View

Adams D, Ito D, Rees M, Seashore-Ludlow B, Puyang X, Ramos A . NAMPT is the cellular target of STF-31-like small-molecule probes. ACS Chem Biol. 2014; 9(10):2247-54. PMC: 4201331. DOI: 10.1021/cb500347p. View

Ahluwalia M, Patton C, Stevens G, Tekautz T, Angelov L, Vogelbaum M . Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas. J Neurooncol. 2010; 102(2):317-21. DOI: 10.1007/s11060-010-0325-3. View

Ancey P, Contat C, Meylan E . Glucose transporters in cancer - from tumor cells to the tumor microenvironment. FEBS J. 2018; 285(16):2926-2943. DOI: 10.1111/febs.14577. View

Ashrafian H, Horowitz J, Frenneaux M . Perhexiline. Cardiovasc Drug Rev. 2007; 25(1):76-97. DOI: 10.1111/j.1527-3466.2007.00006.x. View

Backus K, Correia B, Lum K, Forli S, Horning B, Gonzalez-Paez G . Proteome-wide covalent ligand discovery in native biological systems. Nature. 2016; 534(7608):570-4. PMC: 4919207. DOI: 10.1038/nature18002. View

Bar-Peled L, Kemper E, Suciu R, Vinogradova E, Backus K, Horning B . Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer. Cell. 2017; 171(3):696-709.e23. PMC: 5728659. DOI: 10.1016/j.cell.2017.08.051. View

Benjamin D, Robay D, Hindupur S, Pohlmann J, Colombi M, El-Shemerly M . Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells. Cell Rep. 2018; 25(11):3047-3058.e4. PMC: 6302548. DOI: 10.1016/j.celrep.2018.11.043. View

Bergman A, Carvajal-Gonzalez S, Tarabar S, Saxena A, Esler W, Amin N . Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver-Targeting Acetyl-CoA Carboxylase Inhibitor (PF-05221304): A Three-Part Randomized Phase 1 Study. Clin Pharmacol Drug Dev. 2020; 9(4):514-526. PMC: 7317421. DOI: 10.1002/cpdd.782. View

10.

Bian X, Liu R, Meng Y, Xing D, Xu D, Lu Z . Lipid metabolism and cancer. J Exp Med. 2021; 218(1). PMC: 7754673. DOI: 10.1084/jem.20201606. View

11.

Bose S, Ramesh V, Locasale J . Acetate Metabolism in Physiology, Cancer, and Beyond. Trends Cell Biol. 2019; 29(9):695-703. PMC: 6699882. DOI: 10.1016/j.tcb.2019.05.005. View

12.

Bose S, Zhang C, Le A . Glucose Metabolism in Cancer: The Warburg Effect and Beyond. Adv Exp Med Biol. 2021; 1311:3-15. PMC: 9639450. DOI: 10.1007/978-3-030-65768-0_1. View

13.

Broadfield L, Pane A, Talebi A, Swinnen J, Fendt S . Lipid metabolism in cancer: New perspectives and emerging mechanisms. Dev Cell. 2021; 56(10):1363-1393. DOI: 10.1016/j.devcel.2021.04.013. View

14.

Butler L, Mah C, Machiels J, Vincent A, Irani S, Mutuku S . Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition. Cancer Res. 2021; 81(19):4981-4993. DOI: 10.1158/0008-5472.CAN-20-3863. View

15.

Buyse C, Joudiou N, Warscotte A, Richiardone E, Mignion L, Corbet C . Evaluation of Syrosingopine, an MCT Inhibitor, as Potential Modulator of Tumor Metabolism and Extracellular Acidification. Metabolites. 2022; 12(6). PMC: 9230831. DOI: 10.3390/metabo12060557. View

16.

Cai S, Gao Z . Atorvastatin inhibits proliferation and promotes apoptosis of colon cancer cells via COX-2/PGE2/β-Catenin Pathway. J BUON. 2021; 26(4):1219-1225. View

17.

Camici M, Garcia-Gil M, Pesi R, Allegrini S, Tozzi M . Purine-Metabolising Enzymes and Apoptosis in Cancer. Cancers (Basel). 2019; 11(9). PMC: 6769685. DOI: 10.3390/cancers11091354. View

18.

Cao W, Chen H, Yu Y, Li N, Chen W . Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021; 134(7):783-791. PMC: 8104205. DOI: 10.1097/CM9.0000000000001474. View

19.

Caylioglu D, Meyer R, Hellmold D, Kubelt C, Synowitz M, Held-Feindt J . Effects of the Anti-Tumorigenic Agent AT101 on Human Glioblastoma Cells in the Microenvironmental Glioma Stem Cell Niche. Int J Mol Sci. 2021; 22(7). PMC: 8037174. DOI: 10.3390/ijms22073606. View

20.

Chandel N . Nucleotide Metabolism. Cold Spring Harb Perspect Biol. 2021; 13(7). PMC: 8247561. DOI: 10.1101/cshperspect.a040592. View